Leukemia
Protocol for the treatment of newly diagnosed APL children delineated
Published in Blood Weekly, September 22nd, 2005
According to recent research from Italy, "The role of all-trans retinoic acid (ATRA) in pediatric acute promyelocytic leukemia (APL) is the topic of several ongoing studies. The results of the Italian pediatric experience with the multicentric Gruppo Italiano per le Malattie Ematologiche dell'Adulto (GIMEMA)-Italian Pediatric Hematology and Oncology Group (AIEOP) 'AIDA' (ATRA and idarubicin) trial are presented."
"Of the 983 patients with APL enrolled in this protocol between January 1993 and June 2000, 124 (13%) had younger than 18...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-09-22)
More Articles from Blood Weekly
- Blood Banking
CD34+ cell recovery from cryopreserved autologous stem cell products variable - Blood Safety
Exposure levels of di(2-ethylhexyl) phthalate from blood bags reported - Stem Cell Research
Blood bank notes discovery of embryonic-like stem cells in umbilical cord blood - Tissue Engineering
Bone is formed by hMSCs in biodegradable scaffolds that release Dex/AsP - Tissue Engineering
Tissue engineering techniques used for rotator cuff regeneration - Acute Coronary Syndrome
Clinical trial evaluating rNAPc2 as heparin replacement enrollment initiated - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
